US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist
  • 3.640
  • -0.080-2.15%
Close Mar 26 16:00 ET
  • 3.720
  • +0.080+2.20%
Post 16:39 ET
200.95MMarket Cap-3.22P/E (TTM)

Voyager Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-119.65%-15.31M
38.85%-14.53M
-32.86%-27.97M
-3,682.04%-31.58M
-52.44%58.77M
722.90%77.92M
-94.05%-23.76M
-29.90%-21.05M
95.48%-835K
258.93%123.57M
Net income from continuing operations
-149.12%-65M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
385.14%132.33M
338.70%56.4M
-246.96%-25.9M
-16.35%-22.21M
681.85%124.04M
Operating gains losses
186.52%510K
-8.57%32K
910.53%192K
183.75%227K
34.09%59K
-52.79%178K
--35K
--19K
--80K
--44K
Depreciation and amortization
6.53%4.73M
-24.27%1.01M
19.79%1.13M
28.18%1.39M
11.26%1.2M
-28.27%4.44M
60.07%1.34M
-29.53%945K
-9.80%1.09M
-61.77%1.08M
Change In working capital
152.37%34.86M
120.16%16.69M
-868.03%-21.62M
-256.26%-27.41M
1,723.58%67.2M
-425.13%-66.56M
-1,158.79%-82.78M
107.54%2.82M
2,999.67%17.54M
-108.18%-4.14M
-Change in receivables
197.69%81.31M
121.80%17.49M
-17,024.74%-16.42M
-99.06%206K
419.23%80.03M
-17,622.95%-83.23M
-904.96%-80.24M
100.96%97K
39,860.00%21.98M
-4,866.35%-25.07M
-Change in prepaid assets
-3,556.58%-2.63M
12.44%470K
-424.71%-1.12M
43.44%-1.19M
-156.27%-794K
103.86%76K
232.70%418K
120.75%344K
-1,197.91%-2.1M
862.70%1.41M
-Change in payables and accrued expense
-103.23%-260K
-13.15%3.57M
-51.45%1.72M
-257.33%-2.22M
-429.70%-3.33M
795.93%8.05M
218.81%4.11M
-33.09%3.55M
-343.57%-621K
135.22%1.01M
-Change in other current assets
132.76%4.6M
127.52%1.17M
97.41%991K
184.84%1.39M
122.17%1.04M
-40.33%1.98M
69.18%516K
11.80%502K
-66.94%488K
-56.57%469K
-Change in other current liabilities
-17.19%-3.32M
-121.89%-1.62M
-122.32%-1.59M
-41.74%-995K
230.45%891K
27.77%-2.83M
-48.88%-731K
-44.27%-717K
56.85%-702K
47.74%-683K
-Change in other working capital
-576.33%-44.84M
35.96%-4.38M
-441.27%-5.21M
-1,537.26%-24.61M
-156.84%-10.64M
-60.33%9.41M
-479.07%-6.85M
96.88%-962K
-168.39%-1.5M
-64.90%18.73M
Cash from discontinued investing activities
Operating cash flow
-119.65%-15.31M
38.85%-14.53M
-32.86%-27.97M
-3,682.04%-31.58M
-52.44%58.77M
722.90%77.92M
-94.05%-23.76M
-29.90%-21.05M
95.48%-835K
258.93%123.57M
Investing cash flow
Cash flow from continuing investing activities
33.03%-94.86M
-201.38%-27.2M
140.65%64.35M
-45.74%-35.94M
-762.93%-96.07M
-1,830.00%-141.64M
90.75%26.83M
-555.92%-158.3M
31.74%-24.66M
172.46%14.49M
Net PPE purchase and sale
-8.14%-3.52M
79.47%-155K
67.01%-258K
20.08%-967K
-320.63%-2.14M
-30.71%-3.26M
19.08%-755K
-181.29%-782K
2.58%-1.21M
-1,239.47%-509K
Net investment purchase and sale
34.00%-91.34M
-198.04%-27.05M
141.02%64.61M
-49.13%-34.98M
-726.16%-93.92M
-2,754.52%-138.39M
83.92%27.59M
-550.06%-157.52M
32.78%-23.45M
175.15%15M
Cash from discontinued investing activities
Investing cash flow
33.03%-94.86M
-201.38%-27.2M
140.65%64.35M
-45.74%-35.94M
-762.93%-96.07M
-1,830.00%-141.64M
90.75%26.83M
-555.92%-158.3M
31.74%-24.66M
172.46%14.49M
Financing cash flow
Cash flow from continuing financing activities
238.88%114.02M
24.78%574K
-95.77%14K
-63.11%571K
260.49%112.86M
2,931.08%33.65M
66.67%460K
2,106.67%331K
91.82%1.55M
260,783.33%31.31M
Net common stock issuance
262.39%112.78M
--0
--0
--0
262.39%112.78M
--31.12M
--0
--0
--0
--31.12M
Proceeds from stock option exercised by employees
-50.99%1.24M
24.78%574K
-95.77%14K
-63.11%571K
-57.84%78K
127.39%2.52M
66.67%460K
2,106.67%331K
91.82%1.55M
1,441.67%185K
Cash from discontinued financing activities
Financing cash flow
238.88%114.02M
24.78%574K
-95.77%14K
-63.11%571K
260.49%112.86M
2,931.08%33.65M
66.67%460K
2,106.67%331K
91.82%1.55M
260,783.33%31.31M
Net cash flow
Beginning cash position
-29.94%70.4M
72.59%115.4M
-67.87%79M
-45.91%145.95M
-29.94%70.4M
-15.72%100.47M
-32.03%66.86M
207.96%245.89M
101.89%269.84M
-15.72%100.47M
Current changes in cash
112.79%3.85M
-1,264.96%-41.16M
120.33%36.4M
-179.55%-66.95M
-55.39%75.56M
-60.52%-30.08M
68.32%3.53M
-1,066.08%-179.02M
55.49%-23.95M
1,072.87%169.36M
End cash Position
5.46%74.24M
5.46%74.24M
72.59%115.4M
-67.87%79M
-45.91%145.95M
-29.94%70.4M
-29.94%70.4M
-32.03%66.86M
207.96%245.89M
101.89%269.84M
Free cash flow
-125.22%-18.83M
40.10%-14.68M
-29.28%-28.23M
-1,491.54%-32.55M
-53.98%56.63M
597.75%74.66M
-86.04%-24.52M
-32.45%-21.83M
89.63%-2.05M
257.85%123.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -119.65%-15.31M38.85%-14.53M-32.86%-27.97M-3,682.04%-31.58M-52.44%58.77M722.90%77.92M-94.05%-23.76M-29.90%-21.05M95.48%-835K258.93%123.57M
Net income from continuing operations -149.12%-65M-161.15%-34.49M65.08%-9.04M54.34%-10.14M-109.13%-11.33M385.14%132.33M338.70%56.4M-246.96%-25.9M-16.35%-22.21M681.85%124.04M
Operating gains losses 186.52%510K-8.57%32K910.53%192K183.75%227K34.09%59K-52.79%178K--35K--19K--80K--44K
Depreciation and amortization 6.53%4.73M-24.27%1.01M19.79%1.13M28.18%1.39M11.26%1.2M-28.27%4.44M60.07%1.34M-29.53%945K-9.80%1.09M-61.77%1.08M
Change In working capital 152.37%34.86M120.16%16.69M-868.03%-21.62M-256.26%-27.41M1,723.58%67.2M-425.13%-66.56M-1,158.79%-82.78M107.54%2.82M2,999.67%17.54M-108.18%-4.14M
-Change in receivables 197.69%81.31M121.80%17.49M-17,024.74%-16.42M-99.06%206K419.23%80.03M-17,622.95%-83.23M-904.96%-80.24M100.96%97K39,860.00%21.98M-4,866.35%-25.07M
-Change in prepaid assets -3,556.58%-2.63M12.44%470K-424.71%-1.12M43.44%-1.19M-156.27%-794K103.86%76K232.70%418K120.75%344K-1,197.91%-2.1M862.70%1.41M
-Change in payables and accrued expense -103.23%-260K-13.15%3.57M-51.45%1.72M-257.33%-2.22M-429.70%-3.33M795.93%8.05M218.81%4.11M-33.09%3.55M-343.57%-621K135.22%1.01M
-Change in other current assets 132.76%4.6M127.52%1.17M97.41%991K184.84%1.39M122.17%1.04M-40.33%1.98M69.18%516K11.80%502K-66.94%488K-56.57%469K
-Change in other current liabilities -17.19%-3.32M-121.89%-1.62M-122.32%-1.59M-41.74%-995K230.45%891K27.77%-2.83M-48.88%-731K-44.27%-717K56.85%-702K47.74%-683K
-Change in other working capital -576.33%-44.84M35.96%-4.38M-441.27%-5.21M-1,537.26%-24.61M-156.84%-10.64M-60.33%9.41M-479.07%-6.85M96.88%-962K-168.39%-1.5M-64.90%18.73M
Cash from discontinued investing activities
Operating cash flow -119.65%-15.31M38.85%-14.53M-32.86%-27.97M-3,682.04%-31.58M-52.44%58.77M722.90%77.92M-94.05%-23.76M-29.90%-21.05M95.48%-835K258.93%123.57M
Investing cash flow
Cash flow from continuing investing activities 33.03%-94.86M-201.38%-27.2M140.65%64.35M-45.74%-35.94M-762.93%-96.07M-1,830.00%-141.64M90.75%26.83M-555.92%-158.3M31.74%-24.66M172.46%14.49M
Net PPE purchase and sale -8.14%-3.52M79.47%-155K67.01%-258K20.08%-967K-320.63%-2.14M-30.71%-3.26M19.08%-755K-181.29%-782K2.58%-1.21M-1,239.47%-509K
Net investment purchase and sale 34.00%-91.34M-198.04%-27.05M141.02%64.61M-49.13%-34.98M-726.16%-93.92M-2,754.52%-138.39M83.92%27.59M-550.06%-157.52M32.78%-23.45M175.15%15M
Cash from discontinued investing activities
Investing cash flow 33.03%-94.86M-201.38%-27.2M140.65%64.35M-45.74%-35.94M-762.93%-96.07M-1,830.00%-141.64M90.75%26.83M-555.92%-158.3M31.74%-24.66M172.46%14.49M
Financing cash flow
Cash flow from continuing financing activities 238.88%114.02M24.78%574K-95.77%14K-63.11%571K260.49%112.86M2,931.08%33.65M66.67%460K2,106.67%331K91.82%1.55M260,783.33%31.31M
Net common stock issuance 262.39%112.78M--0--0--0262.39%112.78M--31.12M--0--0--0--31.12M
Proceeds from stock option exercised by employees -50.99%1.24M24.78%574K-95.77%14K-63.11%571K-57.84%78K127.39%2.52M66.67%460K2,106.67%331K91.82%1.55M1,441.67%185K
Cash from discontinued financing activities
Financing cash flow 238.88%114.02M24.78%574K-95.77%14K-63.11%571K260.49%112.86M2,931.08%33.65M66.67%460K2,106.67%331K91.82%1.55M260,783.33%31.31M
Net cash flow
Beginning cash position -29.94%70.4M72.59%115.4M-67.87%79M-45.91%145.95M-29.94%70.4M-15.72%100.47M-32.03%66.86M207.96%245.89M101.89%269.84M-15.72%100.47M
Current changes in cash 112.79%3.85M-1,264.96%-41.16M120.33%36.4M-179.55%-66.95M-55.39%75.56M-60.52%-30.08M68.32%3.53M-1,066.08%-179.02M55.49%-23.95M1,072.87%169.36M
End cash Position 5.46%74.24M5.46%74.24M72.59%115.4M-67.87%79M-45.91%145.95M-29.94%70.4M-29.94%70.4M-32.03%66.86M207.96%245.89M101.89%269.84M
Free cash flow -125.22%-18.83M40.10%-14.68M-29.28%-28.23M-1,491.54%-32.55M-53.98%56.63M597.75%74.66M-86.04%-24.52M-32.45%-21.83M89.63%-2.05M257.85%123.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
KB Home
KBH
+0.92%
Ecopetrol
EC
+0.87%
Petroleo Brasileiro SA Petrobras
PBR
+0.42%
Vale SA
VALE
+0.40%
Taylor Morrison Home
TMHC
+0.12%

Unlock the Full List